Balaxi Pharmaceuticals Limited (BALAXI.NS)

INR 79.69

(0.59%)

Total Assets Summary of Balaxi Pharmaceuticals Limited

Balaxi Pharmaceuticals Limited's latest annual total assets in 2023 was 2.58 Billion INR , up 7.79% from previous year.
Balaxi Pharmaceuticals Limited's latest quarterly total assets in 2024 Q1 was - INR , down -100.0% from previous quarter.
Balaxi Pharmaceuticals Limited reported annual total assets of 2.39 Billion INR in 2022, up 35.81% from previous year.
Balaxi Pharmaceuticals Limited reported annual total assets of 1.76 Billion INR in 2021, up 77.04% from previous year.
Balaxi Pharmaceuticals Limited reported quarterly total assets of 2.58 Billion INR for 2023 FY, up 7.79% from previous quarter.
Balaxi Pharmaceuticals Limited reported quarterly total assets of 2.58 Billion INR for 2023 Q4, down 0.0% from previous quarter.

Annual Total Assets Chart of Balaxi Pharmaceuticals Limited (2023 - 2012)

Historical Annual Total Assets of Balaxi Pharmaceuticals Limited (2023 - 2012)

Year	Total Assets	Total Assets Growth
2023	2.58 Billion INR	7.79%
2022	2.39 Billion INR	35.81%
2021	1.76 Billion INR	77.04%
2020	996.79 Million INR	177.11%
2019	359.71 Million INR	488.93%
2018	61.07 Million INR	262.13%
2017	16.86 Million INR	-34.54%
2016	25.76 Million INR	7117.47%
2015	356.99 Thousand INR	-3.02%
2014	368.09 Thousand INR	-96.94%
2013	12.04 Million INR	-2.76%
2012	12.38 Million INR	0.0%

Year	Total Assets	Total Assets Growth
2024 Q1	- INR	-100.0%
2023 FY	2.58 Billion INR	7.79%
2023 Q4	2.58 Billion INR	0.0%
2023 Q3	- INR	-100.0%
2023 Q2	2.14 Billion INR	0.0%
2023 Q1	- INR	-100.0%
2022 FY	2.39 Billion INR	35.81%
2022 Q4	2.39 Billion INR	0.0%
2022 Q3	- INR	-100.0%
2022 Q2	1.99 Billion INR	0.0%
2022 Q1	- INR	-100.0%
2021 Q4	1.76 Billion INR	0.0%
2021 FY	1.76 Billion INR	77.04%
2021 Q3	- INR	-100.0%
2021 Q2	1.26 Billion INR	0.0%
2021 Q1	- INR	-100.0%
2020 Q3	- INR	-100.0%
2020 Q4	996.79 Million INR	0.0%
2020 Q2	776.51 Million INR	0.0%
2020 FY	996.79 Million INR	177.11%
2020 Q1	- INR	-100.0%
2019 FY	359.71 Million INR	488.93%
2019 Q4	359.71 Million INR	0.0%
2019 Q3	- INR	-100.0%
2019 Q1	- INR	-100.0%
2019 Q2	276.96 Million INR	0.0%
2018 FY	61.07 Million INR	262.13%
2018 Q3	- INR	-100.0%
2018 Q4	61.07 Million INR	0.0%
2018 Q1	- INR	-100.0%
2018 Q2	26.52 Million INR	0.0%
2017 Q2	21.38 Million INR	0.0%
2017 Q3	- INR	-100.0%
2017 Q4	16.86 Million INR	0.0%
2017 FY	16.86 Million INR	-34.54%
2017 Q1	- INR	-100.0%
2016 Q3	- INR	-100.0%
2016 FY	25.76 Million INR	7117.47%
2016 Q4	25.76 Million INR	0.0%
2016 Q2	35.59 Million INR	0.0%
2016 Q1	- INR	-100.0%
2015 FY	356.99 Thousand INR	-3.02%
2015 Q4	356.99 Thousand INR	0.0%
2014 FY	368.09 Thousand INR	-96.94%
2014 Q4	368.09 Thousand INR	0.0%
2013 FY	12.04 Million INR	-2.76%
2012 FY	12.38 Million INR	0.0%

Peer Total Assets Comparison of Balaxi Pharmaceuticals Limited

Name	Total Assets	Total Assets Difference